Tag: COVID-19

March 28, 2022 Off

AstraZeneca’s Evusheld Approved in the EU for Prevention of COVID-19

By Dino Mustafić

AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination, has been granted marketing authorisation in the European Union (EU) for the pre-exposure prophylaxis (prevention) of COVID-19 in a broad population of adults and adolescents aged 12 years and older weighing at least 40 kg.

March 18, 2022 Off

Moderna asks FDA’s approval for the 4th Dose Covid-19 Vaccine

By Dino Mustafić

Moderna has submitted a request to the U.S. Food and Drug Administration (FDA) for an amendment to the emergency use authorization (EUA) to allow for a fourth dose of its COVID-19 vaccine (mRNA-1273) in adults 18 years of age and older who have received an initial booster of any of the authorized or approved COVID-19 vaccines.